Faculty bio page2

Sean G. Yates, MDAssistant Professor

Department of Pathology
Phone: (409) 772-6553
Email: sgyates@utmb.edu

Sean G. Yates, MD

My research efforts are aimed at improving patient safety and clinical outcomes, while also reducing the need for allogeneic blood components and provide insight and helping foster development of diagnostic and prognostic testing to further the advancement of patient blood management and support hemorrhagic and thrombotic diseases.
BS Texas Tech University, Lubbock, TX 2005
MD University of Texas Health Sciences Center at Houston, Houston, TX 2011
Residency University of Texas Southwestern, Dallas, TX 2014
Fellowship University of Texas Southwestern, Dallas, TX 2015
Travel Award South Central Association of Blood Banks; Las Vegas, NV 2015
Travel Award Thrombosis and Hemostasis Summit of North America; Chicago, IL 2014
Teaching Award, Medical Student Curriculum University of Texas Southwestern Medical Center, Dallas, TX 2014
Society for the Advancement of Blood Management 2018 – Present
AABB 2014 – Present
International Society on Thrombosis and Haemostasis 2014 – Present

Reddy M, Tawfik B, Gavva C, Yates S, De Simone N, Hofmann SL, Rambally S, Sarode R. Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency. Transfus Apher Sci. 2016 Dec;55(3):364-367. doi: 10.1016/j.transci.2016.10.002. Epub 2016 Oct 17. PubMed PMID: 27776919.

Related citations

Yates SG, Smith S, Tharpe W, Shen YM, Sarode R. Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban? Transfus Apher Sci. 2016 Oct;55(2):212-215. doi: 10.1016/j.transci.2016.06.005. Epub 2016 Jun 27. PubMed PMID: 27377884.

Cited in PMCRelated citations

Gavva C, Yates SG, Rambally S, Sarode R. Transfusion management of factor V deficiency: three case reports and review of the literature. Transfusion. 2016 Jul;56(7):1745-9. doi: 10.1111/trf.13623. Epub 2016 Apr 28. PubMed PMID: 27125565.

Cited in PMCRelated citations

Shen YM, Tsai J, Taiwo E, Gavva C, Yates SG, Patel V, Frenkel E, Sarode R. Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost. PLoS One. 2016 May 13;11(5):e0155326. doi: 10.1371/journal.pone.0155326. eCollection 2016. PubMed PMID: 27176603; PubMed Central PMCID: PMC4866738.

Free full textCited in PMCRelated citations

Joseph R, Burner J, Yates S, Strickland A, Tharpe W, Sarode R. Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world setting. Transfusion. 2016 Apr;56(4):799-807. doi: 10.1111/trf.13406. Epub 2015 Nov 20. PubMed PMID: 26589481.

Cited in PMCRelated citations

Yates SG, Gavva C, Agrawal D, Sarode R. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures? Transfusion. 2016 Apr;56(4):791-8. doi: 10.1111/trf.13495. Epub 2016 Feb 15. PubMed PMID: 26876945.

Related citations

 Yates S, Sarode R. Reversal of anticoagulant effects in patients with intracerebral hemorrhage. Curr Neurol Neurosci Rep. 2015 Jan;15(1):504. doi: 10.1007/s11910-014-0504-2. Review. PubMed PMID: 25407132.

Cited in PMCRelated citations

 Yates S, Matevosyan K, Rutherford C, Shen YM, Sarode R. Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report. Transfusion. 2014 Aug;54(8):2064-7. doi: 10.1111/trf.12614. Epub 2014 Mar 24. PubMed PMID: 24655327.

Cited in PMC Related citations

 Yates SG, Sarode R. Is platelet transfusion necessary in cirrhotic patients with splenomegaly? Liver Int. 2014 Jan;34(1):164-5. doi: 10.1111/liv.12332. Epub 2013 Oct 16. PubMed PMID: 24102873.

Related citations

 Yates S, Sarode R. Novel thrombin and factor Xa inhibitors: challenges to reversal of their anticoagulation effects. Curr Opin Hematol. 2013 Nov;20(6):552-7. doi: 10.1097/MOH.0b013e328365a164. Review. PubMed PMID: 24104417